Compare Dyne Therapeutics Inc. Common Stock (DYN) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs United Microelectronics Corp — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.06 (market cap $2.86B), while United Microelectronics Corp trades at $20.58 (market cap $55.52B). The key difference: United Microelectronics Corp is far larger — about 19.4× Dyne Therapeutics Inc. Common Stock's market cap, and United Microelectronics Corp pays a 1.79% dividend while Dyne Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and United Microelectronics Corp for 42 Days on average.
| DYN | UMC | |
|---|---|---|
Market Cap | $2.86B | $55.52B |
Volume | 3,341,579 | 8,712,351 |
Sector | Health | Technology |
52-Week High | $26.78 | $28.02 |
52-Week Low | $14.60 | $7.02 |
Typical Hold Time | 0 Days | 42 Days |
Enterprise Value | $2.18B | $52.61B |
Dividend Yield | — | 1.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
UMC trades at $22.39, down 0.71% on the day, with a bullish technical signal despite recent volatility. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $0.54 significantly exceeding the $0.16 forecast. Revenue is projected to grow to $250.7 billion in 2026, with a net income margin rebounding to 32.75%. Cash flow trends show improving operational performance, with net cash flow turning positive in 2025 at $5.66 billion.
The outlook is positive given strong earnings momentum and AI-driven demand, but risks include competitive pressures and sensitivity to semiconductor cycles. Analyst sentiment is mixed with a Hold consensus, though some upgrades to Strong Buy highlight growth potential. The stock's valuation multiples suggest room for appreciation if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
